An oncolytic adenovirus enhanced for Toll-like receptor 9 stimulation increases anti-tumor immune responses and reduces myeloid-derived suppressor cell activity

被引：0
|
作者：
Cerullo, V. [1 ]
Diaconu, I. [1 ]
Vaha-Koskela, M. [1 ]
Romano, V. [1 ]
Ugolini, M. [1 ]
Rouvinen-Lagerstrom, N. [1 ]
Escutenaire, S. [1 ]
Holm, S-L [1 ]
Pesonen, S. [1 ]
Vile, R. [2 ]
Kanerva, A. [1 ]
Hemminki, A. [1 ]
机构：
[1] Univ Helsinki, Canc Gene Therapy Grp, FIN-00290 Helsinki, Finland
[2] Mayo Clin, Dept Immunol, Rochester, MN USA
来源：
HUMAN GENE THERAPY | 2011年 / 22卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：A84 / A84
页数：1
相关论文
共 50 条
  • [41] Blockade of A2b Adenosine Receptor Reduces Tumor Growth and Immune Suppression Mediated by Myeloid-Derived Suppressor Cells in a Mouse Model of Melanoma
    Iannone, Raffaella
    Miele, Lucio
    Maiolino, Piera
    Pinto, Aldo
    Morello, Silvana
    NEOPLASIA, 2013, 15 (12): : 1400 - +
  • [42] In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model
    Silva, Joana M.
    Zupancic, Eva
    Vandermeulen, Gaelle
    Oliveira, Vanessa G.
    Salgado, Ana
    Videira, Mafalda
    Gaspar, Manuela
    Graca, Luis
    Preat, Veronique
    Florindo, Helena F.
    JOURNAL OF CONTROLLED RELEASE, 2015, 198 : 91 - 103
  • [43] Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA Bcl-xL-expressing oncolytic adenovirus through enhanced viral replication and cellular arrest
    Kang, Sujin
    Kang, Dongxu
    Ul Islam, S. M. Bakhtiar
    Je, Suyeon
    Kim, Joo-Hang
    Song, Jae J.
    CELLULAR SIGNALLING, 2015, 27 (06) : 1214 - 1224
  • [44] Additive anti-Tumor Response to the Rabbit VX2 Hepatoma by Combined Radio Frequency Ablation and Toll like Receptor 9 Stimulation
    Behm, Barbara
    Di Fazio, Pietro
    Neureiter, Daniel
    Gress, Thomas
    Michl, Patrick
    Schuppan, Detlef
    Wissniowski, Thaddaeus T.
    HEPATOLOGY, 2014, 60 : 866A - 866A
  • [45] Robust Anti-Tumor Response to the Rabbit VX2 Hepatoma by Combined Radio Frequency Ablation and Toll Like Receptor 9 Stimulation
    Wissniowski, Thaddaeus T.
    Neureiter, Daniel
    Frieser, Markus
    Strobel, Deike
    Schuppan, Detlef
    GASTROENTEROLOGY, 2011, 140 (05) : S593 - S594
  • [46] ADDITIVE ANTI-TUMOR RESPONSE TO THE RABBIT VX2 HEPATOMA BY COMBINED RADIO FREQUENCY ABLATION AND TOLL LIKE RECEPTOR 9 STIMULATION
    Wissniowski, T. T.
    Ocker, M.
    Strobel, D.
    Neureiter, D.
    Schuppan, D.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S131 - S132
  • [47] Toll-Like Receptor 4 (TLR4) Agonism Confers Long-Term Anti-Tumor Immune Memory Against Pancreatic Cancer
    Jain, Tejeshwar
    Ferrantella, Anthony
    Sharma, Prateek
    Vaish, Utpreksha
    Roy, Pooja
    Sethi, Vrishketan
    Giri, Bhuwan
    Dawra, Rajinder
    Saluja, Ashok
    Dudeja, Vikas
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (04) : S284 - S284
  • [48] Toll-like receptor agonist combinations augment mouse T-cell anti-tumor immunity via IL-12-and interferon β-mediated suppression of immune checkpoint receptor expression
    Jeon, Donghwan
    McNeel, Douglas G.
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [49] Rapamycin-based graft-versus-host disease prophylaxis increases the immunosuppressivity of myeloid-derived suppressor cells without affecting T cells and anti-tumor cytotoxicity
    Scheurer, J.
    Reisser, T.
    Leithaeuser, F.
    Messmann, J. J.
    Holzmann, K.
    Debatin, K. M.
    Strauss, G.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2020, 202 (03): : 407 - 422
  • [50] Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine
    Chang, Ming-Cheng
    Chen, Yu-Li
    Chiang, Ying-Cheng
    Cheng, Ya-Jung
    Jen, Yu-Wei
    Chen, Chi-An
    Cheng, Wen-Fang
    Sun, Wei-Zen
    AMERICAN JOURNAL OF CANCER RESEARCH, 2016, 6 (02): : 157 - 172
12345